Combined modality treatment for PET-positive non-hodgkin lymphoma: Favorable outcomes of combined modality treatment for patients with non-hodgkin lymphoma and positive interim or postchemotherapy FDG-PET
Lia M. Halasz, Heather A. Jacene, Paul J. Catalano, Annick D. Van Den Abbeele, Ann Lacasce, Peter M. Mauch, Andrea K. Ng
Dive into the research topics of 'Combined modality treatment for PET-positive non-hodgkin lymphoma: Favorable outcomes of combined modality treatment for patients with non-hodgkin lymphoma and positive interim or postchemotherapy FDG-PET'. Together they form a unique fingerprint.